Dividends Calendar Earnings Calendar
ZYNE

ZYNE | Zynerba Phamaceuticals Inc

Zynerba Phamaceuticals Inc
Category: Pharmaceutical company
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Devon, Pennsylvania, United States

Trade prices

  • Volume:
  • Market Cap: 58.45M
  • Prev closed: 4.73
  • Open: 4.95
  • High: 4.95
  • Low: 4.57
  • 52 week low: 2.55
  • 52 week high: 15.7
  • Dividends:No Dividends

Next ER: May 11, 2022 



Top Stories (ZYNE)

    Company Profile

    Zynerba (NASDAQ: ZYNE) is dedicated to improving the lives of people with rare and near rare neuropsychiatric disorders where there is a high unmet medical need by pioneering the development and commercialization of next-generation pharmaceutically-produced cannabinoid therapeutics formulated for transdermal delivery.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    May 10, 2022
    March 14, 2022- / -0.272- / -
    March 1, 2022-0.22 / -0.2633- / -
    November 15, 2021-0.26 / -0.252- / -
    August 11, 2021- / -0.2229- / -
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    May 13, 2022 0.856 0.950
    1.010
    0.840
    1.22M -4.89%
    May 12, 2022 0.900 0.920
    1.000
    0.890
    409.45K -5.27%
    May 11, 2022 0.950 1.140
    1.150
    0.950
    415.08K -12.83%
    May 10, 2022 1.090 1.170
    1.230
    1.075
    411.48K -4.39%
    May 9, 2022 1.140 1.210
    1.231
    1.120
    198.10K -8.8%
    May 6, 2022 1.250 1.330
    1.330
    1.240
    166.51K -6.72%
    May 5, 2022 1.340 1.410
    1.450
    1.330
    114.99K -7.59%
    May 4, 2022 1.450 1.460
    1.460
    1.340
    132.53K 2.84%
    May 3, 2022 1.410 1.460
    1.470
    1.390
    93.40K -3.42%
    May 2, 2022 1.460 1.410
    1.460
    1.380
    166.59K 3.55%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2007
    • Employees:28

    News

    News for (ZYNE)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Armando Anido
    • General Counsel :  Suzanne M. Hanlon
    • Chief Medical Officer :  Joseph M. Palumbo (Md, Fapa, Macpsych)

    Talk about Zynerba Phamaceuticals Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on May 11, 2022 (Same day)

    dis wen pam prgo zyne bynd fvrr pfgc fosl ste suz ifrx 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 83
    HOLD 17
    SELL 0

    Their Official Profiles 

    TwitterLinkedIn

    Peers / Similar stocks 

    xlv 

    Other stocks 

    s kmx lrcx bks etr sptn schw agn vips xray veev roku 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Currency Trading For Dummies
    Buy on Amazon

    Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up?